Hear how the Program of Glyco-Immunology and Oncology (PGIO) is deciphering cancer’s ‘glyco code’ to pave the way for more precise diagnostics and next generation immunotherapies.
This approach may eventually help guide personalized treatment decisions for patients diagnosed with these cancers
In this guest editorial, Richard Knight Senior Director, Medical Affairs, Thermo Fisher Scientific, explores how success in transplantation is measured in years, not hours, and how lab professionals provide the critical data needed to navigate the high-stakes journey of post-operative care
All patients were negative for minimal residual disease, and no patients experienced progression to active multiple myeloma during the median 15.3 months of follow-up
National Institutes of Health awards The Research OutSmarts Endometriosis team an $850,000 prize over one year to accelerate the development of a non-invasive diagnostic test
The Content Innovation Engine integrates Akoya's spatial biology platform and Quanterix's immunoassay infrastructure to unlock cancer biology and accelerate clinical application
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic NSCLC
The AACR will present the 2026 AACR Award for Lifetime Achievement in Cancer Research to Dr. James P. Allison, Fellow of the AACR Academy, during the AACR Annual Meeting 2026
The investigational drug led to objective response and disease control in patients with late-stage disease
Discover how Hannah Hill, biomedical scientist at Bedfordshire Hospitals NHS Foundation Trust, is raising public awareness and driving diagnostic excellence for Medical Lab Professionals Week
Forage Evolution co-founder Cameron Kitzinger talks with SelectScience to celebrate Medical Laboratory Professionals Week 2026
As part of Lab Professionals Week, Aida Noor shares what it means to build a biomedical science career beyond the bench
Discover how Manchester-based expert Tahmina Hussain is bridging the gap between clinical pathology and biomedical science degree apprenticeships at the University of Salford
Discover how Chukwuyem Usifo, specialist biomedical scientist at Northern Care Alliance NHS Foundation Trust, is driving quality in skin cancer diagnostics for Lab Professionals Week 2026
Through a real-world patient story, CLSI explores how laboratory medicine can shape diagnosis and care in complex cases.
The AACR will present the 2026 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research during the AACR Annual Meeting 2026
Discover how Dr. Vasiliki E Kalodimou uses advanced flow cytometry to bridge the gap between laboratory precision and personalized biotherapies for Lab Professionals Week 2026
Responses were seen in patients who were not treated with prior KRAS G12C inhibitors as well as those whose disease progressed on prior KRAS G12C inhibitors
Discover how Quadram Institute researcher Dr Amisha Modasia is bridging the gap between dietary fiber and whole body wellness to celebrate Medical Laboratory Professionals Week 2026
An updated trial analysis presented at AACR 2026 showed that the investigational KRAS G12D inhibitor zoldonrasib demonstrated clinical activity with a favorable safety profile in previously treated KRAS G12D‑mutant NSCLC patients
In this guest editorial, Jon Sherlock, Senior Director, Product Management at Thermo Fisher Scientific explores why supporting laboratory professionals is the key to bridging the gap between innovation and patient outcomes
Extended immunotherapy showed manageable long‑term safety in adolescents and young adults with alveolar soft part sarcoma, according to phase II data presented at AACR 2026
The AACR will honor leaders from government and the advocacy community with awards for distinguished service in support of cancer research at the AACR Annual Meeting 2026
Cast your vote in the 2026 Scientists' Choice Awards for the product that has made the most difference to your lab
Comprehensive analysis of one of the largest datasets with harmonized variant calls from over 8,000 cancer whole genomes enables researchers worldwide to uncover rare drivers, new targets, and AI-ready insights that could reshape precision oncology
